顶部联系方式

Time of issue:2018-03-12 00:00:00

Have Any Questions?  Mabspace BiosciencesInfo@mabspacebio.com 迈博斯生物0512-86861701

搜索
迈博斯生物

语言切换

Time of issue:2019-11-21 00:00:00
这是描述信息

TECHNOLOGY

>>
In Vivo Pharmacology Evaluation

In Vivo Pharmacology Evaluation

  • Categories:Technology
  • Time of issue:2018-01-24 00:00:00
  • Views:0
Description:
Description:
Information

MabSpace has established multiple types of models to assess the in vivo efficacy of the immuno-therapeutic antibodies

1) Classic syngeneic models

2) Humanized syngeneic models in which the tumor cells express human PD-L1 e.g. MC38. (see example below)

3) Humannized syngeneic models in which both PD-1 in mice and PD-L1 in tumor cells have been engineered to be human origin

4) PDX tumor implanted in humanized mice resonstituted with CD34+ hematopoietic stem cells

 

Additional capability has been established for the evaluation of antibody penetration and receptor target occupany in the tumor

 

Example 

Thereaputic humanized syngeneic models in which MC38 tumor cells express human PD-L1 was treated

with PD-L1 blocking antibodies (MSB2311 or MPDL-3280A)

 

迈博斯

 

迈博斯

Scan the QR code to read on your phone

页脚关于我们

Time of issue:2019-11-23 00:00:00

页脚管道

Time of issue:2019-11-23 00:00:00

页脚新闻

Time of issue:2019-11-23 00:00:00

页脚人力资源

Time of issue:2019-11-23 00:00:00

页脚联系方式

Time of issue:2019-11-23 00:00:00

页脚版权

Time of issue:2019-11-23 00:00:00

Copyright © 2019 Mabspace Biosciences All rights reserved

页脚备案

Time of issue:2019-11-23 00:00:00